C07D 471/02
In which the condensed system contains two hetero rings
Official title: in which the condensed system contains two hetero rings
C07D471/02 (In which the condensed system contains two hetero rings) appears on 21,228 US grants and 25,984 published applications in this corpus.
Search patents in C07D- Granted patents
- 21,228
- Published applications
- 25,984
- Assignees
- 5,138
- Inventors
- 46,388
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 109 | 0 |
| 1977 | 84 | 0 |
| 1978 | 87 | 0 |
| 1979 | 49 | 0 |
| 1980 | 89 | 0 |
| 1981 | 96 | 0 |
| 1982 | 81 | 0 |
| 1983 | 59 | 0 |
| 1984 | 87 | 0 |
| 1985 | 110 | 0 |
| 1986 | 128 | 0 |
| 1987 | 121 | 0 |
| 1988 | 141 | 0 |
| 1989 | 148 | 0 |
| 1990 | 178 | 0 |
| 1991 | 197 | 0 |
| 1992 | 201 | 0 |
| 1993 | 210 | 0 |
| 1994 | 176 | 0 |
| 1995 | 206 | 0 |
| 1996 | 253 | 0 |
| 1997 | 330 | 0 |
| 1998 | 263 | 0 |
| 1999 | 237 | 0 |
| 2000 | 230 | 0 |
| 2001 | 281 | 62 |
| 2002 | 293 | 350 |
| 2003 | 361 | 528 |
| 2004 | 298 | 832 |
| 2005 | 325 | 729 |
| 2006 | 373 | 707 |
| 2007 | 387 | 787 |
| 2008 | 401 | 794 |
| 2009 | 508 | 929 |
| 2010 | 570 | 1060 |
| 2011 | 548 | 1013 |
| 2012 | 723 | 953 |
| 2013 | 919 | 1028 |
| 2014 | 931 | 1187 |
| 2015 | 1057 | 1182 |
| 2016 | 903 | 1254 |
| 2017 | 1069 | 1124 |
| 2018 | 971 | 1185 |
| 2019 | 981 | 1242 |
| 2020 | 950 | 1280 |
| 2021 | 860 | 1155 |
| 2022 | 734 | 1255 |
| 2023 | 704 | 1557 |
| 2024 | 755 | 1503 |
| 2025 | 881 | 1308 |
| 2026 | 575 | 980 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Crystalline form of heterocyclic compound as protein kinase inhibitor6 Oct 2026US 12,753,174 B2Hk Inno. N Corporation
- FGFR inhibitor compound and use thereof6 Oct 2026US 12,753,179 B2Shenzhen Kangsu Pharmaceutical Technology Co., Ltd.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Compounds for treating hereditary spastic paraplegia8 Oct 2026US 2026/0306465 A1Children's Medical Center Corporation
- Technologies targeting cell states8 Oct 2026US 2026/0306640 A1Auron Therapeutics, Inc.
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
Most cited
By later US patents
- 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use451US 4,689,338 ARiker Laboratories, Inc. · 1987
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines350US 5,389,640 AMinnesota Mining and Manufacturing Company · 1995
- Alkynylamino-nucleotides340US 5,047,519 AE. I. Du Pont de Nemours and Company · 1991
- Olefinic 1H-imidazo(4,5-c)quinolin-4-amines319US 4,929,624 AMinnesota Mining and Manufacturing Company · 1990